ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Extracellular Vesicles Mediate Endothelial to Mesenchymal Transition and Tubular Senescence in Renal Antibody- Mediated Rejection by Inducing Complement Activation

G. Castellano, R. Franzin, A. Stasi, C. Divella, G. Merlotti, M. Quaglia, F. Sallustio, G. Stallone, V. Cantaluppi, L. Gesualdo

Emergency and Organ Transplantation, University of Bari, Bari, Italy

Meeting: 2020 American Transplant Congress

Abstract number: 209

Keywords: Age factors, Endothelial activation, Rejection

Session Information

Session Name: Basic: Acute Rejection

Session Type: Oral Abstract Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:45pm

 Presentation Time: 3:51pm-4:03pm

Location: Virtual

*Purpose: EVs (Extracellular vesicles), circulating microparticles able to mediate cell-to cell communication, are emerging as pivotal in different kidney diseases. Renal Antibody-Mediated Rejection (AMR) is characterized by endothelial to mesenchymal transition (EndMT) and accelerated senescence in tubular epithelial cells (RPTEC). However, the potential role of EVs in accelerating renal aging and early fibrosis after AMR is not well understood.

*Methods: Renal biopsies and serum purified EVs from 10 Acute and Chronic AMR patients were collected. Inflammaging (p16INK4a) and EndMT markers (CD31/αSMA) were evaluated by IHC and IF. EVs were isolated by ultracentrifugation and characterized by Nanoparticle Tracking Analysis (Nanosight, NTA EV/ml) and FACS (Attune Nxt). RPTEC and Eahy926 culture were incubated with EVs (5e+4 EVs/cells target for 24h); then to assess EndMT we performed FACS. Cellular senescence was investigated by qPCR for p21, p53, Klotho and CYP1B1 and SA-β-gal staining were performed. mRNA level of C3 and CFH were also measured.

*Results: Renal AMR biopsies showed significant tubular senescence as indicated by p16 expression; p16 was significantly upregulated in Chronic compared with Acute AMR biopsies (p<0.05). The AMR biopsies showed positivity for EndMT, as indicated by CD31 decrease and interstitial αSMA upregulation (p<0.05). In AMR patients sera, EVs appeared to be significantly augmented in acute AMR compared to healthy serum controls, in a higher manner than chronic AMR (NTA, p=0.0154)[RF1] . In vitro, the exposure of RTEC to AMR-derived EVs induced senescence as observed by significant increase in SA-β-gal+ cells and p21, p53, CYP1B1 gene expression (p<0.05). Furthermore, AMR derived EVs induced Klotho gene expression downregulation compared to basal RPTEC culture. In accordance, the AMR derived EVs induced the EndMT as observed by FACS with the downregulation of CD31, VE-cadherin (CD144) and increase of Vimentin and Collagen I (p=0.025). Finally, EVs from AMR patients induced a significant increase in C3 gene expression with concomitant downregulation in CFH in RPTEC. [RF1]Ho chiesto al gruppo di Cantaluppi il valore NTA EV/ML DELLE EV dei tx controllo

*Conclusions: These results suggest a putative role for circulating AMR derived-EVs in inducing the tubular inflammaging by local complement activation and early fibrosis by EndMT. The EVs cargo characterization might highlight novel targets for therapeutic intervention.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Castellano G, Franzin R, Stasi A, Divella C, Merlotti G, Quaglia M, Sallustio F, Stallone G, Cantaluppi V, Gesualdo L. Extracellular Vesicles Mediate Endothelial to Mesenchymal Transition and Tubular Senescence in Renal Antibody- Mediated Rejection by Inducing Complement Activation [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/extracellular-vesicles-mediate-endothelial-to-mesenchymal-transition-and-tubular-senescence-in-renal-antibody-mediated-rejection-by-inducing-complement-activation/. Accessed May 16, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences